Dr. Novack presents ophthalmology research at University of Wisconsin

Dr. Novack presenting at Grand Rounds, University of Wisconsin, September 2019

Dr. Novack returned to the University of Wisconsin to present in the Department of Ophthalmology Grand Rounds.  His spoke about what it would take to develop a drug to prevent the development of myopia (nearsightedness) in children.   Myopia has reached epidemic proportions around the world, and is a major public health issue.  He also spoke to the ophthalmology residents on the topic of drop volume (size) for eyedrops.  His work on these subjects has been published in Eye and Contact Lens and The Ocular Surface, respectively.

 

Sonoma Eye – Dr. Novack chair symposium on research and outcomes

At the 3rd Annual Sonoma Eye, meeting, Dr. Novack chaired a symposium on two areas of interest – basic research in ocular inflammation and retinal disease and clinical outcomes.  Dr. Novack presented current thinking on endpoints in approvals of novel therapeutics in ophthalmology.  He also moderated the discussion on how to best use pre-clinical models to aid in drug development.  Including Dr. Novack, there were 3 speakers from the University of California, Davis.

 

Presentations at the AAO 2017

Dr. Novack will be giving several presentations at the Annual Meeting of the American Academy of Ophthalmology in New Orleans in November 2017.  On 9 November, he will lead a breakfast with FDA at the OIS AAO.  On 11 November, he will give a talk at the Glaucoma Sub-specialty day on New Molecules in Glaucoma Development.  On 14 November, he will give a talk on “An update on newly FDA-approved drugs and new drugs in clinical trials” at the Prevent Blindness America symposium.  Finally, he will be part of a course on “Empowering glaucoma patients to take better care of themselves.”